Beck Lauren C, Berrington Janet E, Stewart Christopher J
Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Newcastle Neonatal Services, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Pediatr Res. 2025 Feb;97(2):493-496. doi: 10.1038/s41390-024-03520-w. Epub 2024 Aug 25.
Meta-analysis of probiotic administration to very preterm or very low birthweight (VP/VLBW) infants shows reduced risk of necrotising enterocolitis (NEC). Separately reported outcomes for extremely preterm infants (<28 weeks) or extremely low birth weight infants (<1000 g) (EP/ELBW) are lacking meaning some clinicians do not administer probiotics to EP/ELBW infants despite their high risk of NEC. We present data showing the gut microbiome is impacted in EP/ELBW infants in a similar manner to VP/VLBW infants, suggesting that risk reduction for necrotising enterocolitis that is microbiome driven will also be seen in EP/ELBW infants, making probiotic administration beneficial.
对极早产儿或极低出生体重(VP/VLBW)婴儿给予益生菌的荟萃分析表明,坏死性小肠结肠炎(NEC)的风险降低。目前缺乏针对极早产儿(<28周)或极低出生体重儿(<1000克)(EP/ELBW)单独报告的结果,这意味着一些临床医生尽管EP/ELBW婴儿患NEC的风险很高,但仍不给他们使用益生菌。我们提供的数据表明,EP/ELBW婴儿的肠道微生物群受到的影响与VP/VLBW婴儿相似,这表明在EP/ELBW婴儿中也会出现由微生物群驱动的坏死性小肠结肠炎风险降低的情况,这使得给予益生菌有益。